Next Article in Journal
Sulfated-Polysaccharide Fraction from Red Algae Gracilaria caudata Protects Mice Gut Against Ethanol-Induced Damage
Next Article in Special Issue
Examination of Marine-Based Cultivation of Three Demosponges for Acquiring Bioactive Marine Natural Products
Previous Article in Journal
An Acute Case of Intoxication with Cyanobacteria and Cyanotoxins in Recreational Water in Salto Grande Dam, Argentina
Previous Article in Special Issue
Kinase Inhibitors from Marine Sponges
Correction published on 7 May 2013, see Mar. Drugs 2013, 11(5), 1490-1491.

Pectenotoxin-2 from Marine Sponges: A Potential Anti-Cancer Agent—A Review

Laboratory of Immunobiology, Department of Marine Life Sciences, Jeju National University, Jeju 690-756, Korea
Department of Urology, Chungbuk National University College of Medicine, Cheongju 361-763, Korea
Department of Biochemistry, College of Oriental Medicine, Dongeui University, Busan 614-052, Korea
Department of Biomaterial Control (BK21 program), Graduate School, and Blue-Bio Industry RIC, Dongeui University, Busan 614-052, Korea
Author to whom correspondence should be addressed.
Mar. Drugs 2011, 9(11), 2176-2187;
Received: 2 September 2011 / Revised: 9 October 2011 / Accepted: 19 October 2011 / Published: 2 November 2011
(This article belongs to the Special Issue Bioactive Compound from Marine Sponges)
Pectenotoxin-2 (PTX-2), which was first identified as a cytotoxic entity in marine sponges, has been reported to display significant cytotoxicity to human cancer cells where it inhibits mitotic separation and cytokinesis through the depolymerization of actin filaments. In the late stage of endoreduplication, the effects of PTX-2 on different cancer cells involves: (i) down-regulation of anti-apoptotic Bcl-2 members and IAP family proteins; (ii) up-regulation of pro-apoptotic Bax protein and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor 1/receptor 2 (DR4/DR5); and (iii) mitochondrial dysfunction. In addition, PTX-2 induces apoptotic effects through suppression of the nuclear factor κB (NF-κB) signaling pathway in several cancer cells. Analysis of cell cycle regulatory proteins showed that PTX-2 increases phosphorylation of Cdc25c and decreases protein levels of Cdc2 and cyclin B1. Cyclin-dependent kinase (Cdk) inhibitor p21 and Cdk2, which are associated with the induction of endoreduplication, were upregulated. Furthermore, it was found that PTX-2 suppressed telomerase activity through the transcriptional and post-translational suppression of hTERT. The purpose of this review was to provide an update regarding the anti-cancer mechanism of PTX-2, with a special focus on its effects on different cellular signaling cascades. View Full-Text
Keywords: pectenotoxin-2; cancer; cell cycle; apoptosis pectenotoxin-2; cancer; cell cycle; apoptosis
Show Figures

MDPI and ACS Style

Kim, G.-Y.; Kim, W.-J.; Choi, Y.H. Pectenotoxin-2 from Marine Sponges: A Potential Anti-Cancer Agent—A Review. Mar. Drugs 2011, 9, 2176-2187.

AMA Style

Kim G-Y, Kim W-J, Choi YH. Pectenotoxin-2 from Marine Sponges: A Potential Anti-Cancer Agent—A Review. Marine Drugs. 2011; 9(11):2176-2187.

Chicago/Turabian Style

Kim, Gi-Young, Wun-Jae Kim, and Yung Hyun Choi. 2011. "Pectenotoxin-2 from Marine Sponges: A Potential Anti-Cancer Agent—A Review" Marine Drugs 9, no. 11: 2176-2187.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop